Risk Factors for Exertional Heat Illness
Prospective Investigation of Risk Factors for Exertional Heat Illness
1 other identifier
observational
783
1 country
1
Brief Summary
The arduous nature of military training and operations require personnel to encounter high heat load, e.g., during intense physical exertion, particularly in the heat. These conditions reduce operational effectiveness and expose personnel to a risk of incapacitation and death from exertional heat illness (EHI). The aim of this study is to examine traditional and novel risk factors that may increase thermal strain and EHI likelihood in military recruits undergoing strenuous physical exercise.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 28, 2021
CompletedStudy Start
First participant enrolled
June 11, 2021
CompletedFirst Posted
Study publicly available on registry
July 28, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 22, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2025
CompletedMarch 19, 2025
October 1, 2024
3.1 years
May 28, 2021
March 17, 2025
Conditions
Outcome Measures
Primary Outcomes (22)
Body mass index in EHI and control group
Baseline
Fitness in EHI and control group - participants ranked by time to complete fitness test
Baseline
Core temperature in EHI and control group
1 Day
Heart rate in EHI and control group
2 Hours
Urine osmolality in EHI and control group
Baseline
Sleep quality and quantity, measured by Pittsburgh Sleep Quality Index, in EHI and control group
0-21 Scale. Higher score indicates worse outcome
Throughout study - up to 1 week
Sleep quality, measured by actigraphy, between EHI and control group
Throughout study - up to 1 week
Sleep quantity, measured by actigraphy, between EHI and control group
Throughout study - up to 1 week
Circulating Interleukin 6 in EHI and control group
Baseline
Circulating C-Reactive Protein in EHI and control group
Baseline
Circulating Creatine kinase in EHI and control group
Baseline
Circulating Aspartate Aminotransferase in EHI and control group
Baseline
Circulating Alanine Aminotransferase in EHI and control group
Baseline
Circulating Claudin 3 in EHI and control group
Baseline
Circulating Zonulin in EHI and control group
Baseline
Circulating Lipopolysaccharide binding protein in EHI and control group
Baseline
Circulating immunoglobulin E in EHI and control group
Baseline
Salivary cortisol in EHI and control group
Throughout study - up to 1 week
Detection of infectious pathogens in EHI and control groups
Throughout study - up to 1 week
Respiratory illness symptomology, measured by Jackson common cold questionnaire, in EHI and control group
0-24 Scale. Higher score indicates worse outcome
Throughout study - up to 1 week
Gastrointestinal illness symptomology, measured by gastrointestinal symptoms questionnaire, in EHI and control group
0-10 Scale per symptom. Higher score indicates worse outcome
Throughout study - up to 1 week
Abundance and diversity of gastrointestinal microbiota in EHI and control group
Baseline
Study Arms (2)
Exertional heat illness
Participants who experience an atypical elevation in thermal strain or an EHI undergoing strenuous physical exercise.
Control
Participants who do not experience an atypical elevation in thermal strain or an EHI undergoing strenuous physical exercise.
Interventions
Core temperature will be monitored on the day of exercise
Questionnaires will be completed at baseline and on the day of exercise
Heart rate will be monitored on the day of exercise
Urine samples will be collected at baseline and on the day of exercise
Sleep will be monitored at baseline and on the day of exercise
Saliva samples will be collected at baseline and on the day of exercise
Throat swab samples will be collected at baseline and on the day of exercise
Stool samples will be collected at baseline and on the day of exercise
Eligibility Criteria
Participants who experience and participants who do not experience an atypical elevation in thermal strain or an EHI undergoing strenuous physical exercise.
You may qualify if:
- Men and women aged 17-35 years enrolled in military training
You may not qualify if:
- Self-report as pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Liverpool John Moores Universitylead
- Institute of Naval Medicine (UK)collaborator
- CTCRM Lympstone (UK)collaborator
- University of Portsmouth (UK)collaborator
- Public Health Walescollaborator
- Bangor University (UK)collaborator
- Headquarters Army Recruiting and Initial Training Command (UK)collaborator
- Defence Science and Technology (UK)collaborator
Study Sites (1)
Commando Training Centre Royal Marine
Lympstone, Devon, EX8 5AR, United Kingdom
Biospecimen
Saliva sample, stool sample
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 28, 2021
First Posted
July 28, 2021
Study Start
June 11, 2021
Primary Completion
July 22, 2024
Study Completion
July 1, 2025
Last Updated
March 19, 2025
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share